Trinity Biotech plc (ADR) (NASDAQ:TRIB)
CAPS Rating:
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Recs
New acquesitions will lead to improved growth earning - stock is now under valued - company in a strong position